Royal DSM, a global purpose-led science-based company, today announces its partnership with Albéa, the world’s leading cosmetic packaging supplier, to bring sustainable packaging for its sun care formulation prototypes and achieve its vision of delivering a fully sustainable sun care offering to customers.
Royal DSM, a global science-based company in Nutrition, Health and Sustainable Living, and METEX NØØVISTA, an industrial subsidiary of METABOLIC EXPLORER jointly announced today the successful start of commercial production of their new cosmetic grade of PDO. Produced at an industrial plant in France, TILAMAR® PDO with NØØVISTA is 100% bio-sourced from non-GMO feedstocks and the first European-made cosmetic grade PDO.
At ISBS World Congress 2021, DSM scientist Remo Campiche, PhD presented details of a new method he has developed with our partner Newtone Technologies. It involves digitally transferring pigmentation observed on volunteers’ inner forearms to their faces to visualize the effectiveness of specific ingredients.
Royal DSM, a global science-based company active in nutrition, health and sustainable living, today announces the launch of three different forms of hyaluronic acid. With the new HYA-ACT™ range, DSM strengthens its hyaluronic acid portfolio to deliver on growing market expectations for less-invasive, reliable and effective beauty care solutions.
Royal DSM, a global science-based company in Nutrition, Health and Sustainable Living, starts the market roll-out of its first European-made, cosmetic grade of PDO. TILAMAR® PDO with NØØVISTA™ is 100% bio-sourced from non-GMO feedstocks and also certified as Microbiome-friendly according to the industry-recognized MyMicrobiome test for dry and oily skin areas.
As we, DSM, are monitoring the ever-changing climate of the COVID-19 pandemic, we want to assure you that our number one priority is the health and safety of our employees, customers and suppliers.
DSM’s Personal Care & Aroma Ingredients business unit, one of the industry’s leading suppliers to the personal care, home care and fine fragrance markets, prepares to submit the necessary data to the FDA to support a generally recognized as safe and effective (GRASE) determination for Bemotrizinol (BEMT).
DSM’s Personal Care & Aroma Ingredients business unit, one of the industry’s leading suppliers to the personal care, home care and fine fragrance markets, proposes an accelerated scientific approach to confirm GRASE status for most UV-filter products in the United States.
To kick off 2020 DSM’s President Gareth Barker, would like to say THANK YOU for a fantastic 2019 before revealing some of the great things we’re really excited about for 2020.
This exclusive global strategic collaboration to deliver the first made-in-Europe cosmetic grade of PDO, 100% bio-sourced from non-GMO feedstocks under the DSM TILAMAR® brand, TILAMAR® PDO with NØØVISTA.
DSM’s Michele Marchini and Sebastien Mongiat reflected in an interview after In-cosmetics global 2018 on key personal care trends they noticed and how DSM is responding to these.
To support customers that desire to develop sunscreen products for the Hawaii market, DSM has created 2 new sunscreen formulations that meet the new ingredient requirements.
To review the ban’s impact on sun care stakeholders, in particular brand owners, ingredient manufacturers and sun care consumers, Silke Adamietz invited representatives from different departments of DSM to discuss the issues.
A deep understanding of skin biology and physiology in combination with relevant consumer and market insights is our expertise’s. Our core competences in skin care are dedicated to the areas of the skin microbiome, skin ageing, skin tone and CORNEOCARE™ - a holistic approach that creates ultimate skin appearance and sensation via building a strong epidermal barrier. Don’t miss our four scientific papers which tackle these areas – and thereore have been recognized by the industry as one of the 10% most downloaded scientific papers in the 12 months following online publication in 2018 and 2019.
The collaboration aims to bring a new probiotic technology-based skin care active for the treatment of acne to market. DSM will be S-Biomedic’s world-wide exclusive manufacturing & go-to-market partner for this active and plans to start commercialization of the new technology within the next 18-24 months.
At IFSCC 2021, our scientists presented new innovations to address skin resilience, skin aging and hair loss and new findings on skin moisturization and the skin microbiome.
